Recommended publications

Journal and link to the article
Bulten-Ducuing et al. 2023 The therapeutic potential of psychedelics: the European regulatory perspective The Lancet
Holze et al.
2022 Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.
McCulloch et al.
2022 Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses.
Neuroscience & Biobehavioral Reviews
Carhart-Harris et al. 
2021  Trial of psilocybin versus escitalopram for depression. 
New England Journal of Medicine  
Vizeli et al.
2021 Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis.
Scientific Reports
Stenbæk et al.
2020 Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.
Journal of Psychopharmacology
Madsen et al.
2019 Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.   Neuropsychopharmacology
Preller et al.
2018 Phenomenology, structure, and dynamic of psychedelic states.
Current Topics in Behavioral Neurosciences
Preller et al.
2018 Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
Kuypers et al.
2016 Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
Páleníček et al.
2011 Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics.


  • October 2022
    ECNP Satellite Meeting
  • 6 July 2022
    Virtual start-up meeting (only for members of the Psychedelic research TWG)

Research projects